Showing 3 results for Soltanpour
Jafari S, Soltanpour F, Soudbakhsh A, Safavi E, Rokni Yazdi H, Navipour R, Hajizadeh E,
Volume 64, Issue 8 (13 2006)
Abstract
Background: Community-acquired pneumonia could be a life-threatening condition especially in elderly patients. The factors influencing the outcome in elderly patients are thought to be different from those in young adults. We compared the clinical and paraclinical profiles in elderly and nonelderly patients with community-acquired pneumonias.
Methods: In this cross-sectional study, seventy nine patients who were hospitalized with community acquired pneumonia over a period of one year were included. Patients' medical records were reviewed and data related to comorbid conditions, signs and symptoms, laboratory and radiographic findings were gathered using a checklist.
Results: The clinical features, laboratory parameters and complications from pneumonia were almost similar in 41 elderly (group I, age ≥65years) and 38 young (group II, age<65years) subjects. Delirium was seen more in elderly group (p=0.05). The average body temperature and pulse rate were significantly higher in nonelderly group. Sixty one percent of elderly patients and 21% of young patients have Po2 less than 60 (p=0.02). Smoking (29.1%), neurological disturbances (19%), congestive heart failure (15.2%), chronic obstructive pulmonary disease and diabetes mellitus (13.9%) were associated comorbidities in both groups. In non elderly group, immune compromise and IV drug use were more common as underlying comorbid conditions. Two of three mortalities were due to elder patients.
Conclusion: Community acquired pneumonia could have more serious clinical and abnormal laboratory features in the elderly than younger patients. Mortality rate may be higher in older patients. Comorbid conditions are frequently seen in both elderly and nonelderly patients with community acquired pneumonia, but IV drug use and immune compromise are more frequent in nonelderly patients.
Modarres M, Mosavi A, Mohammadifar M, Behtash N, Ghaemmaghami F, Soltanpour F,
Volume 64, Issue 11 (7 2006)
Abstract
Background: Access to a safe and efficient chemotherapy regimen for improving the survival and live quality is a goal in ovarian carcinoma. Despite surgery is the base treatment of ovarian cancer, but in most patients chemotherapy is used due to progression of their disease. This study designed to compare two important chemotherapy regimens.
Methods: This historical cohort study compared two chemotherapy regimen cisplatin (75mg/m2)+ cyclophosphamide (750mg/m2), versus taxol (175mg/m2)+ carboplatinium (GFR+25)AUC between 1998-2005 in valiasr hospital. In this study toxicities of two regimes were compared. The survival function in these two groups were analysed with Kaplan-Meire curve.
Results: Gastrointestinal and mucosal toxicity were significantly higher in CP group compared TC group (p=0.02). Also there were no significant relation between decrease of serum CA125 and patient remission length in CP group but in other group with decrease of CA125 in lower than three cycle we had an increase in patient remission period. (P=0.02). Disease free interval in cisplatin group was longer versus taxol group (p<0.05), there was no significant difference in overall survival in two group.
Conclusion: This study revealed that cisplatin plus cyclophosphamide regimen can yet be used as a chemotherapy treatment in ovarian cancer. In this study there was no significant benefit in taxol regimen compared CP. In the adjuvant therapy of epithelial ovarian carcinoma.
Abbasali Imani Fooladi , Elnaz Parvizi , Mohammadjavad Soltanpour , Ali Ahmadi ,
Volume 73, Issue 9 (December 2015)
Abstract
Background: Bacterial pneumonia is one of the most common causes of morbidity and mortality, and accurate diagnosis and treatment of the pneumonia causative agent, especially in polybacterial cases, is difficult and much appreciated. The aim of this study was to determine the causative agents and antimicrobial susceptibility of polybacterial pneumonia in patients with lower respiratory tract infections.Methods: In this retrospective cross-sectional study, 167 cases with symptoms of lower respiratory tract infection (LRTI), admitted since March 2010 to March 2013 to Baqiyatallah Hospital, Tehran, were studied. Bronchoalveolar lavage (BAL) samples have been obtained from all these patients and have been investigated for the presence of bacterial causative agent, presence of polybacterial pattern of the infection, and the pattern of antimicrobial susceptibility testing by disc diffusion method. Also, the samples have been studied for the presence of Mycobacterium tuberculosis through culture of specific media, separately.Results: From 167 patients (62 women and 105 men), 90 cases were positive for the presence of bacterial pathogens while 77 cases were negative by culture. The incidence of bacterial pneumonia was not statistically different between men and women. Totally 117 bacterial isolates were obtained belonging to 15 different bacterial species. Mycobacterium tuberculosis (25%), Pseudomonas aeruginosa (15%) and Staphylococcus aureus (14%) were the most frequent pathogens identified. 72 percent of pneumonic cases were monobacterial infections and the others were polybacterial infections (23% two-bacterial, and 5% three-bacteria). The highest antibiotic resistance rate was seen for amoxicillin and the lowest one was seen for vancomycin.Conclusion: This study found that the prevalence of bacterial pneumonia increases with age, and also is caused by different etiologic agents. A high percentage of negative cases may be due to fastidious bacteria, viral agents, and previous antibiotic therapy. Due to high levels of resistance to antimicrobial agents, accurate diagnosis and susceptibility testing of pneumonic patients is essential.
